ACP1 and melanoma: Coherently, data reported in The Human Protein Atlas database show that in melanoma patients, unfavorable prognosis is associated with high LMW-PTP expression levels, thereby confirming the role of this enzyme in regulating the in vivo survival and proliferation rate of melanoma cells [71,101].